Zoledronic and Restasis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zoledronic (zoledronic acid) and Restasis (cyclosporine). Common drug interactions include chest discomfort among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Zoledronic and Restasis. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

On Jul, 14, 2026

53 people who take Zoledronic and Restasis together, and have interactions are studied.

Zoledronic and Restasis drug interactions.

What are the common drug interactions of Zoledronic and Restasis, by gender? *:

female:

Chest discomfort
Chronic fatigue syndrome (disorder that causes extreme fatigue)
Cyst (a closed sac)
Decreased activity
Decreased appetite
Disturbance in attention
Fibromyalgia (a long-term condition which causes pain all over the body)
Flatulence (flatus expelled through the anus)
Diarrhoea
Dizziness

male:

Nausea (feeling of having an urge to vomit)
Arthralgia (joint pain)
Vomiting
White blood cell count decreased
Diarrhoea
Ear discomfort
Ear infection
Gait disturbance
Headache (pain in head)
Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Zoledronic and Restasis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pyrexia (fever)
Alopecia (absence of hair from areas of the body)
Diarrhoea
Dry skin
Headache (pain in head)
Hepatic enzyme increased
Hot flush (sudden feelings of heat)
Infusion related reaction
Insomnia (sleeplessness)
Multiple allergies (allergy to multiple agents)

60+:

Pain in extremity
Diarrhoea
Dizziness
Drug ineffective
Dysphonia (speech disorder attributable to a disorder of phonation)
Dyspnoea (difficult or laboured respiration)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Laryngitis (inflammation of the larynx)
Loss of proprioception (loss of senses of body and parts)
Nasal oedema (fluid collection in nose)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 30.19%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 9 people, 16.98%
Osteoporosis (bones weak and more likely to break): 9 people, 16.98%
Constipation: 7 people, 13.21%
Essential Thrombocythaemia (chronic blood cancer): 7 people, 13.21%
Pain: 7 people, 13.21%
Insomnia (sleeplessness): 7 people, 13.21%
Asthma: 5 people, 9.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 9.43%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 5 people, 9.43%

* Approximation only. Some reports may have incomplete information.

Do you take Zoledronic and Restasis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously